Close Menu

Precipio

NEW YORK (GenomeWeb News) – Transgenomic said today that it is collaborating with New York University Langone Medical Center to use its Ice-Cold-PCR technology to study the molecular basis of non-small cell lung cancer and therapeutic response to existing and novel NSCLC therapies.

NEW YORK (GenomeWeb News) - Transgenomic today said that it has signed a definitive agreement to acquire the global rights to a multi-gene prognostic test for scoliosis from Axial Biotech.

Transgenomic has been awarded a Phase I Small Business Technology Transfer grant from the National Institutes of Health to conduct initial studies on the feasibility of using Ice-Cold-PCR for the early detection of pancreatic cancer.

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Wednesday that revenues in the second quarter increased 18 percent year over year.

NEW YORK (GenomeWeb News) – Transgenomic and the Medical College of Wisconsin today announced an agreement under which Transgenomic will offer next-generation sequencing-based testing from the MCW Clinical Sequencing Program.

Cepheid Launches Standardized Xpert BCR-ABL Monitor Test
Cepheid has released an updated version of its Xpert BCR-ABL Monitor test, which now incorporates "lot-specific standardization" based on World Health Organization BCR-ABL guidelines.

NEW YORK (GenomeWeb News) – Transgenomic today announced it has received confirmation of Medicare coverage for its clopidogrel response test.

Mark Boguski, a faculty member of Harvard Medical School and Beth Israel Deaconess Medical Center, has founded Genome Health Solutions, a new company focused on personalized genomic medicine.

NEW YORK (GenomeWeb News) – Mark Boguski, a faculty member at the Harvard Medical School and Beth Israel Deaconess Medical Center, has co-founded a new consulting company called Genome Health Solutions.

Transgenomic has appointed Matthew Beer as vice president of business development for oncology; and John McAuliffe as vice president of business development for neurology.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.